APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Disease Detection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Disease Detection Market Analysis and Forecast 2026-2032

4 March 2026203 pages

Choose your research edition.

Industry ResearchAI Disease Detection Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Disease Detection Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI Disease Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Disease Detection Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Disease Detection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global AI Disease Detection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Disease Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Disease Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Disease Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Disease Detection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Disease Detection include Nuvoola, Oatmeal Health, NIRAMAI, iCAD, MultiplAI Health, Medicus AI, AEYE Health, NURA and Kheiron, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Disease Detection, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Disease Detection, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Disease Detection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Disease Detection revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Disease Detection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Disease Detection revenue, projected growth trends, production technology, application and end-user industry.

AI Disease Detection Segment by Company

Nuvoola

Oatmeal Health

NIRAMAI

iCAD

MultiplAI Health

Medicus AI

AEYE Health

NURA

Kheiron

Aidoc

Aiberry

Ellipsis Health

Omdena

Innowise Group

Syndell

Klizo Solutions

Wysa

AI Disease Detection Segment by Type

Physical Ailment

Mental Illness

AI Disease Detection Segment by Application

Hospital

Enterprise

Individual

Others

AI Disease Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Disease Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Disease Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Disease Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Disease Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Disease Detection company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Disease Detection revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Disease Detection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Physical Ailment Major Player Table 3. Mental Illness Major Player Table 4. Global AI Disease Detection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Enterprise Major Player Table 7. Individual Major Player Table 8. Others Major Player Table 9. AI Disease Detection Industry Trends Table 10. AI Disease Detection Industry Drivers Table 11. AI Disease Detection Industry Opportunities and Challenges Table 12. AI Disease Detection Industry Restraints Table 13. Global AI Disease Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI Disease Detection Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI Disease Detection Market Share by Region (2021-2026) Table 16. Global AI Disease Detection Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI Disease Detection Market Share by Region (2027-2032) Table 18. Global AI Disease Detection Revenue by Players (US$ Million) & (2021-2026) Table 19. Global AI Disease Detection Revenue Market Share by Players (2021-2026) Table 20. Global AI Disease Detection Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI Disease Detection Key Players Headquarters & Area Served Table 22. Global AI Disease Detection Players, Product Type & Application Table 23. Global AI Disease Detection Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global AI Disease Detection by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global AI Disease Detection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI Disease Detection Revenue by Type (2021-2026) & (US$ Million) Table 28. Global AI Disease Detection Revenue by Type (2027-2032) & (US$ Million) Table 29. Global AI Disease Detection Revenue Market Share by Type (2021-2026) Table 30. Global AI Disease Detection Revenue Market Share by Type (2027-2032) Table 31. Global AI Disease Detection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI Disease Detection Revenue by Application (2021-2026) & (US$ Million) Table 33. Global AI Disease Detection Revenue by Application (2027-2032) & (US$ Million) Table 34. Global AI Disease Detection Revenue Market Share by Application (2021-2026) Table 35. Global AI Disease Detection Revenue Market Share by Application (2027-2032) Table 36. Nuvoola Company Information Table 37. Nuvoola Business Overview Table 38. Nuvoola AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Nuvoola AI Disease Detection Product Portfolio Table 40. Nuvoola Recent Development Table 41. Oatmeal Health Company Information Table 42. Oatmeal Health Business Overview Table 43. Oatmeal Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Oatmeal Health AI Disease Detection Product Portfolio Table 45. Oatmeal Health Recent Development Table 46. NIRAMAI Company Information Table 47. NIRAMAI Business Overview Table 48. NIRAMAI AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. NIRAMAI AI Disease Detection Product Portfolio Table 50. NIRAMAI Recent Development Table 51. iCAD Company Information Table 52. iCAD Business Overview Table 53. iCAD AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. iCAD AI Disease Detection Product Portfolio Table 55. iCAD Recent Development Table 56. MultiplAI Health Company Information Table 57. MultiplAI Health Business Overview Table 58. MultiplAI Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MultiplAI Health AI Disease Detection Product Portfolio Table 60. MultiplAI Health Recent Development Table 61. Medicus AI Company Information Table 62. Medicus AI Business Overview Table 63. Medicus AI AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Medicus AI AI Disease Detection Product Portfolio Table 65. Medicus AI Recent Development Table 66. AEYE Health Company Information Table 67. AEYE Health Business Overview Table 68. AEYE Health AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AEYE Health AI Disease Detection Product Portfolio Table 70. AEYE Health Recent Development Table 71. NURA Company Information Table 72. NURA Business Overview Table 73. NURA AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. NURA AI Disease Detection Product Portfolio Table 75. NURA Recent Development Table 76. Kheiron Company Information Table 77. Kheiron Business Overview Table 78. Kheiron AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Kheiron AI Disease Detection Product Portfolio Table 80. Kheiron Recent Development Table 81. Aidoc Company Information Table 82. Aidoc Business Overview Table 83. Aidoc AI Disease Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Aidoc AI Disease Detection Product Portfolio Table 85. Aidoc Recent Development Table 86. Aiberry Company Information Table 87. Aiberry Business Overview Table 88. Aiberry AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Aiberry AI Disease Detection Product Portfolio Table 90. Aiberry Recent Development Table 91. Ellipsis Health Company Information Table 92. Ellipsis Health Business Overview Table 93. Ellipsis Health AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Ellipsis Health AI Disease Detection Product Portfolio Table 95. Ellipsis Health Recent Development Table 96. Omdena Company Information Table 97. Omdena Business Overview Table 98. Omdena AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Omdena AI Disease Detection Product Portfolio Table 100. Omdena Recent Development Table 101. Innowise Group Company Information Table 102. Innowise Group Business Overview Table 103. Innowise Group AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Innowise Group AI Disease Detection Product Portfolio Table 105. Innowise Group Recent Development Table 106. Syndell Company Information Table 107. Syndell Business Overview Table 108. Syndell AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Syndell AI Disease Detection Product Portfolio Table 110. Syndell Recent Development Table 111. Klizo Solutions Company Information Table 112. Klizo Solutions Business Overview Table 113. Klizo Solutions AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Klizo Solutions AI Disease Detection Product Portfolio Table 115. Klizo Solutions Recent Development Table 116. Wysa Company Information Table 117. Wysa Business Overview Table 118. Wysa AI Disease Detection Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Wysa AI Disease Detection Product Portfolio Table 120. Wysa Recent Development Table 121. North America AI Disease Detection Revenue by Type (2021-2026) & (US$ Million) Table 122. North America AI Disease Detection Revenue by Type (2027-2032) & (US$ Million) Table 123. North America AI Disease Detection Revenue by Application (2021-2026) & (US$ Million) Table 124. North America AI Disease Detection Revenue by Application (2027-2032) & (US$ Million) Table 125. North America AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America AI Disease Detection Revenue by Country (2021-2026) & (US$ Million) Table 127. North America AI Disease Detection Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe AI Disease Detection Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe AI Disease Detection Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe AI Disease Detection Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe AI Disease Detection Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe AI Disease Detection Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe AI Disease Detection Revenue by Country (US$ Million) & (2027-2032) Table 135. China AI Disease Detection Revenue by Type (2021-2026) & (US$ Million) Table 136. China AI Disease Detection Revenue by Type (2027-2032) & (US$ Million) Table 137. China AI Disease Detection Revenue by Application (2021-2026) & (US$ Million) Table 138. China AI Disease Detection Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia AI Disease Detection Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia AI Disease Detection Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia AI Disease Detection Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia AI Disease Detection Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia AI Disease Detection Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia AI Disease Detection Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia AI Disease Detection Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA AI Disease Detection Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA AI Disease Detection Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA AI Disease Detection Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA AI Disease Detection Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA AI Disease Detection Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA AI Disease Detection Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. AI Disease Detection Image Figure 2. Global AI Disease Detection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Disease Detection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Physical Ailment Image Figure 5. Mental Illness Image Figure 6. Global AI Disease Detection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI Disease Detection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Enterprise Image Figure 10. Individual Image Figure 11. Others Image Figure 12. Global AI Disease Detection Market Size (US$ Million) & (2021-2032) Figure 13. Global AI Disease Detection Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI Disease Detection Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global AI Disease Detection Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI Disease Detection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI Disease Detection Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global AI Disease Detection Revenue Market Share by Type (2021-2032) Figure 20. Global AI Disease Detection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI Disease Detection Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global AI Disease Detection Revenue Market Share by Application (2021-2032) Figure 23. North America AI Disease Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America AI Disease Detection Revenue Share by Type (2021-2032) Figure 25. North America AI Disease Detection Revenue Share by Application (2021-2032) Figure 26. North America AI Disease Detection Revenue Share by Country (2021-2032) Figure 27. United States AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe AI Disease Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe AI Disease Detection Revenue Share by Type (2021-2032) Figure 32. Europe AI Disease Detection Revenue Share by Application (2021-2032) Figure 33. Europe AI Disease Detection Revenue Share by Country (2021-2032) Figure 34. Germany AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China AI Disease Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China AI Disease Detection Revenue Share by Type (2021-2032) Figure 44. China AI Disease Detection Revenue Share by Application (2021-2032) Figure 45. Asia AI Disease Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia AI Disease Detection Revenue Share by Type (2021-2032) Figure 47. Asia AI Disease Detection Revenue Share by Application (2021-2032) Figure 48. Asia AI Disease Detection Revenue Share by Region (2021-2032) Figure 49. Japan AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA AI Disease Detection Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA AI Disease Detection Revenue Share by Type (2021-2032) Figure 57. SAMEA AI Disease Detection Revenue Share by Application (2021-2032) Figure 58. SAMEA AI Disease Detection Revenue Share by Country (2021-2032) Figure 59. Brazil AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt AI Disease Detection Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Physical Ailment
  • Mental Illness
Applications
  • Hospital
  • Enterprise
  • Individual
  • Others
Companies covered
  • Nuvoola
  • Oatmeal Health
  • NIRAMAI
  • iCAD
  • MultiplAI Health
  • Medicus AI
  • AEYE Health
  • NURA
  • Kheiron
  • Aidoc
  • Aiberry
  • Ellipsis Health
  • Omdena
  • Innowise Group
  • Syndell
  • Klizo Solutions
  • Wysa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Disease Detection Market by Type
  3. 1.2.1 Global AI Disease Detection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Physical Ailment
  5. 1.2.3 Mental Illness
  6. 1.3 AI Disease Detection Market by Application
  7. 1.3.1 Global AI Disease Detection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Enterprise
  10. 1.3.4 Individual
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 AI Disease Detection Market Dynamics
  1. 2.1 AI Disease Detection Industry Trends
  2. 2.2 AI Disease Detection Industry Drivers
  3. 2.3 AI Disease Detection Industry Opportunities and Challenges
  4. 2.4 AI Disease Detection Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Disease Detection Market Perspective (2021-2032)
  2. 3.2 Global AI Disease Detection Growth Trends by Region
  3. 3.2.1 Global AI Disease Detection Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Disease Detection Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Disease Detection Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Disease Detection Revenue by Players
  2. 4.1.1 Global AI Disease Detection Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Disease Detection Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Disease Detection Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Disease Detection Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Disease Detection Key Players Headquarters & Area Served
  7. 4.4 Global AI Disease Detection Players, Product Type & Application
  8. 4.5 Global AI Disease Detection Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Disease Detection Market CR5 and HHI
  11. 4.6.3 2025 AI Disease Detection Tier 1, Tier 2, and Tier 3
5 AI Disease Detection Market Size by Type
  1. 5.1 Global AI Disease Detection Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Disease Detection Revenue by Type (2021-2032)
  3. 5.3 Global AI Disease Detection Revenue Market Share by Type (2021-2032)
6 AI Disease Detection Market Size by Application
  1. 6.1 Global AI Disease Detection Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Disease Detection Revenue by Application (2021-2032)
  3. 6.3 Global AI Disease Detection Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Nuvoola
  2. 7.1.1 Nuvoola Company Information
  3. 7.1.2 Nuvoola Business Overview
  4. 7.1.3 Nuvoola AI Disease Detection Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Nuvoola AI Disease Detection Product Portfolio
  6. 7.1.5 Nuvoola Recent Developments
  7. 7.2 Oatmeal Health
  8. 7.2.1 Oatmeal Health Company Information
  9. 7.2.2 Oatmeal Health Business Overview
  10. 7.2.3 Oatmeal Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Oatmeal Health AI Disease Detection Product Portfolio
  12. 7.2.5 Oatmeal Health Recent Developments
  13. 7.3 NIRAMAI
  14. 7.3.1 NIRAMAI Company Information
  15. 7.3.2 NIRAMAI Business Overview
  16. 7.3.3 NIRAMAI AI Disease Detection Revenue and Gross Margin (2021-2026)
  17. 7.3.4 NIRAMAI AI Disease Detection Product Portfolio
  18. 7.3.5 NIRAMAI Recent Developments
  19. 7.4 iCAD
  20. 7.4.1 iCAD Company Information
  21. 7.4.2 iCAD Business Overview
  22. 7.4.3 iCAD AI Disease Detection Revenue and Gross Margin (2021-2026)
  23. 7.4.4 iCAD AI Disease Detection Product Portfolio
  24. 7.4.5 iCAD Recent Developments
  25. 7.5 MultiplAI Health
  26. 7.5.1 MultiplAI Health Company Information
  27. 7.5.2 MultiplAI Health Business Overview
  28. 7.5.3 MultiplAI Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MultiplAI Health AI Disease Detection Product Portfolio
  30. 7.5.5 MultiplAI Health Recent Developments
  31. 7.6 Medicus AI
  32. 7.6.1 Medicus AI Company Information
  33. 7.6.2 Medicus AI Business Overview
  34. 7.6.3 Medicus AI AI Disease Detection Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Medicus AI AI Disease Detection Product Portfolio
  36. 7.6.5 Medicus AI Recent Developments
  37. 7.7 AEYE Health
  38. 7.7.1 AEYE Health Company Information
  39. 7.7.2 AEYE Health Business Overview
  40. 7.7.3 AEYE Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AEYE Health AI Disease Detection Product Portfolio
  42. 7.7.5 AEYE Health Recent Developments
  43. 7.8 NURA
  44. 7.8.1 NURA Company Information
  45. 7.8.2 NURA Business Overview
  46. 7.8.3 NURA AI Disease Detection Revenue and Gross Margin (2021-2026)
  47. 7.8.4 NURA AI Disease Detection Product Portfolio
  48. 7.8.5 NURA Recent Developments
  49. 7.9 Kheiron
  50. 7.9.1 Kheiron Company Information
  51. 7.9.2 Kheiron Business Overview
  52. 7.9.3 Kheiron AI Disease Detection Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Kheiron AI Disease Detection Product Portfolio
  54. 7.9.5 Kheiron Recent Developments
  55. 7.10 Aidoc
  56. 7.10.1 Aidoc Company Information
  57. 7.10.2 Aidoc Business Overview
  58. 7.10.3 Aidoc AI Disease Detection Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Aidoc AI Disease Detection Product Portfolio
  60. 7.10.5 Aidoc Recent Developments
  61. 7.11 Aiberry
  62. 7.11.1 Aiberry Company Information
  63. 7.11.2 Aiberry Business Overview
  64. 7.11.3 Aiberry AI Disease Detection Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Aiberry AI Disease Detection Product Portfolio
  66. 7.11.5 Aiberry Recent Developments
  67. 7.12 Ellipsis Health
  68. 7.12.1 Ellipsis Health Company Information
  69. 7.12.2 Ellipsis Health Business Overview
  70. 7.12.3 Ellipsis Health AI Disease Detection Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Ellipsis Health AI Disease Detection Product Portfolio
  72. 7.12.5 Ellipsis Health Recent Developments
  73. 7.13 Omdena
  74. 7.13.1 Omdena Company Information
  75. 7.13.2 Omdena Business Overview
  76. 7.13.3 Omdena AI Disease Detection Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Omdena AI Disease Detection Product Portfolio
  78. 7.13.5 Omdena Recent Developments
  79. 7.14 Innowise Group
  80. 7.14.1 Innowise Group Company Information
  81. 7.14.2 Innowise Group Business Overview
  82. 7.14.3 Innowise Group AI Disease Detection Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Innowise Group AI Disease Detection Product Portfolio
  84. 7.14.5 Innowise Group Recent Developments
  85. 7.15 Syndell
  86. 7.15.1 Syndell Company Information
  87. 7.15.2 Syndell Business Overview
  88. 7.15.3 Syndell AI Disease Detection Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Syndell AI Disease Detection Product Portfolio
  90. 7.15.5 Syndell Recent Developments
  91. 7.16 Klizo Solutions
  92. 7.16.1 Klizo Solutions Company Information
  93. 7.16.2 Klizo Solutions Business Overview
  94. 7.16.3 Klizo Solutions AI Disease Detection Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Klizo Solutions AI Disease Detection Product Portfolio
  96. 7.16.5 Klizo Solutions Recent Developments
  97. 7.17 Wysa
  98. 7.17.1 Wysa Company Information
  99. 7.17.2 Wysa Business Overview
  100. 7.17.3 Wysa AI Disease Detection Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Wysa AI Disease Detection Product Portfolio
  102. 7.17.5 Wysa Recent Developments
8 North America
  1. 8.1 North America AI Disease Detection Revenue (2021-2032)
  2. 8.2 North America AI Disease Detection Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Disease Detection Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Disease Detection Revenue by Type (2027-2032)
  5. 8.3 North America AI Disease Detection Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Disease Detection Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Disease Detection Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Disease Detection Revenue by Application (2027-2032)
  9. 8.5 North America AI Disease Detection Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Disease Detection Revenue by Country
  11. 8.6.1 North America AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Disease Detection Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Disease Detection Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Disease Detection Revenue (2021-2032)
  2. 9.2 Europe AI Disease Detection Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Disease Detection Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Disease Detection Revenue by Type (2027-2032)
  5. 9.3 Europe AI Disease Detection Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Disease Detection Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Disease Detection Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Disease Detection Revenue by Application (2027-2032)
  9. 9.5 Europe AI Disease Detection Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Disease Detection Revenue by Country
  11. 9.6.1 Europe AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Disease Detection Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Disease Detection Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Disease Detection Revenue (2021-2032)
  2. 10.2 China AI Disease Detection Revenue by Type (2021-2032)
  3. 10.2.1 China AI Disease Detection Revenue by Type (2021-2026)
  4. 10.2.2 China AI Disease Detection Revenue by Type (2027-2032)
  5. 10.3 China AI Disease Detection Revenue Share by Type (2021-2032)
  6. 10.4 China AI Disease Detection Revenue by Application (2021-2032)
  7. 10.4.1 China AI Disease Detection Revenue by Application (2021-2026)
  8. 10.4.2 China AI Disease Detection Revenue by Application (2027-2032)
  9. 10.5 China AI Disease Detection Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Disease Detection Revenue (2021-2032)
  2. 11.2 Asia AI Disease Detection Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Disease Detection Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Disease Detection Revenue by Type (2027-2032)
  5. 11.3 Asia AI Disease Detection Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Disease Detection Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Disease Detection Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Disease Detection Revenue by Application (2027-2032)
  9. 11.5 Asia AI Disease Detection Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Disease Detection Revenue by Country
  11. 11.6.1 Asia AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Disease Detection Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Disease Detection Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Disease Detection Revenue (2021-2032)
  2. 12.2 SAMEA AI Disease Detection Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Disease Detection Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Disease Detection Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Disease Detection Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Disease Detection Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Disease Detection Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Disease Detection Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Disease Detection Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Disease Detection Revenue by Country
  11. 12.6.1 SAMEA AI Disease Detection Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Disease Detection Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Disease Detection Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst